MedTrace Logo

Evaluation of Candidate Biomarkers to Predict Disease Severity and Acute Kidney Injury in Sepsis Patients

NCT05310812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2023-11-30

No results posted yet for this study

Summary

Investigators predict that the information that can be obtained in terms of renal functions before clinical development in sepsis patients can be valuable in terms of guiding treatment algorithms, planning renal replacement therapies and using drugs that are toxic to the kidneys.

Conditions

Interventions

DIAGNOSTIC_TEST

Biochemical evaluation.

Blood will be taken for biochemical evaluation-ELISA.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Figen ESEN, Prof. Dr. · Istanbul University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-06-30
Completion
2022-11-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310812 on ClinicalTrials.gov